Advocacy & Policy

Members of the House Energy and Commerce Committee sent a September 15 letter to the Health and Human Services (HHS) Office of Inspector General (OIG) requestin

The AAMC Sept. 14 submitted a comment letter on the Centers for Medicare and Medicaid Services’ (CMS) Treatment of Third Party Payers in Calculating Uncompensat

The Medicaid and CHIP Payment and Access Commission (MACPAC) Sept. 15 met to discuss Medicaid disproportional share hospital (DSH) policy, as well as possible r

House and Senate leadership and appropriators continue discussions about a continuing resolution (CR) to extend current funding levels for all federal agencies

The Department of Health and Human Services (HHS) Sept. 16 issued the final rule on clinical trials registration and results submission, specifying new requirem

The AAMC submitted a letter to the FDA on the collection,and reporting of age, race, and ethnicity data.

The Association of American Medical Colleges (AAMC or Association) welcomes this opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS’s

An educational primer on the regulation of laboratory developed tests (LDTs.)

AAMC offers comments related to evaluating and reporting on age, race and ethnicity sub-group data in medical device clinical studies.

The AAMC Sept. 6 submitted a comment letter on the Centers for Medicare and Medicaid Services’ (CMS’s) Outpatient Prospective Payment System (OPPS) proposed rul